BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Pfizer, Ranbaxy sales and marketing update

Ranbaxy's Ranbaxy Laboratories Ltd. subsidiary launched an authorized generic version of Pfizer's Caduet amlodipine besylate/atorvastatin in the U.S. The hypertension and hypercholesterolemia drug combines hypertension drug...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >